|
| |
Image Results
Loading...
Loading...
Pedf Genvec Pages on BioPortfolio:
|
BioPortfolio - GenVec, Inc. - GenVec Announces Third Quarter 2009 ...
GenVec will hold a conference call at 10:00 a.m. EST on Friday, November 6, 2009 to ... To access the webcast or the replay, go to www.genvec.com, ...
http://www.bioportfolio.com/news/GenVec-Announces-Third-Quar...
|
BioPortfolio - GenVec, Inc. - FDA Grants Orphan Drug Designation ...
TNFerade program at GenVec by offering potential clinical development and ... GenVec, Inc. is a biopharmaceutical company developing novel therapeutic drugs
...
http://www.bioportfolio.com/news/FDA-Grants-Orphan-Drug-Desi...
|
BioPortfolio - BLD Science PGC Scientifics - Profile
Amy C. Cavers has joined. NeurogesX as. GenVec Signs New · Contract to Support ... signed a contract with GenVec for the development of influenza and HIV ...
http://www.bioportfolio.com/biocorporate/28073-BLD+Science+P...
|
BioPortfolio - SAIC - Profile
GenVec and SAIC-Frederick signs contract to develop influenza and HIV vaccines ... SAIC-Frederick Signs $22M Contract with GenVec (GNVC) for Flu and HIV ...
http://www.bioportfolio.com/biocorporate/29507-SAIC.pdf...
|
BioPortfolio - Tuoxin Biochemical Technology & Science Co.,Ltd ...
5th November, 2009 GenVec, Inc. GAITHERSBURG, Md., Nov. 5. /PRNewswire-FirstCall / -- ... a contract with GenVec for the development of influenza and ...
http://www.bioportfolio.com/biocorporate/31305-Tuoxin+Bioche...
|
BioPortfolio - Hauser Chemical Research Incorporated - Profile
GenVec was awarded a SBIR grant, valued at approximately. $300000, from the National. Cancer Institute of the NIH to support the research of a new ...
http://www.bioportfolio.com/biocorporate/4800-Hauser+Chemica...
|
BioPortfolio - Hair Cells
Download PDF containing detailed information. PDF Version .... GenVec, Inc. ( NASDAQ: GNVC) is a biopharmaceutical company developing novel gene-based ...
http://www.bioportfolio.com/indepth/Hair_Cells.html...
| Results from other life science and pharmaceutical sites:
BioMed Central | PDF | AdGVVEGF121.10 (GenVec).
AdGVVEGF121.10 (GenVec). N Basara Current Opinion in Investigational Drugs 2001 2:792-795. Access to the full text of this article requires a subscription. ...
http://www.biomedcentral.com/content/pdf/cd-412892.pdf...
|
Alternate serotype adenovector provides long-term therapeutic gene ...
Both the Ad5 and Ad35 vectors expressing GFP, luciferase or PEDF were constructed using GenVec's AdFAST technology, which employs homologous
recombination ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613074/...
|
BioMed Central | PDF | Technology evaluation: TNFerade, GenVec
Technology evaluation: TNFerade, GenVec. R Kircheis, E Wagner Current Opinion in Molecular Therapeutics 2003 5:437-448 ...
http://www.biomedcentral.com/content/pdf/cd-500978.pdf...
|
Combating Ocular Disease
Another company looking closely at the problem of administration is GenVec (www. genvec.com). GenVec is using its adenovector technology to deliver the PEDF ...
http://www.genengnews.com/articles/chitem_print.aspx?aid=208...
|
Molecular Therapy - Abstract of article: Persistent Expression of ...
Persistent Expression of PEDF in the Eye Using High-capacity Adenovectors ... Correspondence: Joseph T. Bruder, GenVec, Inc. 65 West Watkins Mill Road, ...
http://www.nature.com/mt/journal/v16/n12/abs/mt2008211a.html...
|
Article : Combating Ocular Disease Genetic Engineering ...
1 Apr 2007 ... GenVec is using its adenovector technology to deliver the PEDF gene to ocular cells, where it triggers production of the therapeutic protein ...
http://www.genengnews.com/articles/chitem.aspx?aid=2080&chid...
|
Molecular Therapy - Abstract of article: Repeat Administration of ...
1Vector Sciences, GenVec, Inc., Gaithersburg,Maryland,USA ... Persistent Expression of PEDF in the Eye Using High-capacity Adenovectors ...
http://www.nature.com/mt/journal/v16/n8/abs/mt2008124a.html...
|
National Eye Institute Symposium On Pigment Epithelium-Derived ...
A crystal structure of pigment epithelium-derived factor (PEDF). ... Two of these organizations, BioProducts Maryland and GenVec, made generous financial
...
http://www.nei.nih.gov/news/meetings/PEDF_Symposium/index.as...
|
Maryland - National Institutes of Health (NIH) - Home Page
... "GENVEC, INC.","5R21EY017608-02","7624613","Reiter, Christopher Davis"," Novel regulation of the anti-angiogenic activity of PEDF by pro-angiogenic MMPs"
...
http://silk.nih.gov/public/cbz2zoz.@www.fy2009.maryland.csv...
|
Persistent expression of PEDF in the eye using high-capacity ...
GenVec, Inc. Research Department, Gaithersburg, Maryland 20878, USA. ... We have assessed the durability of PEDF expression and the induction of ocular ...
http://www.ncbi.nlm.nih.gov/pubmed/18827806...
|
|
